Exhibit A

AGREEMENT

The undersigned agree that this Amendment No. 3 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Adamas Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

Armistice Capital, LLC
By:	/s/ Steven Boyd
Steven Boyd
Managing Member
/s/ Steven Boyd
Steven Boyd